Let's Make things Better
JNS: AstraZeneca, the manufacturer of the Covishield COVID-19 vaccine, has announced its decision to withdraw the vaccine from circulation, citing “commercial reasons.” The company stated that the vaccine is no …
AstraZeneca Withdraws COVID-19 Vaccine Due to ‘Commercial Reasons’ Read More
JNS: The prices of Covid vaccine, COVISHIELD (Serum Institute) and COVAXIN (Bharat Biotech) have been slashed for private hospitals. The price of the Covishield vaccine has been reduced from 600 rupees …
Covishield, Covaxin price cuts to Rs 225 per dose for private hospitals Read More
JNS: Amidst rising COVID cases in European and few Asian countries, the National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap between the first and second dose of …
“Reduce Covishield vaccine gap” : NTAGI Read More
JNS: The subject expert committee (SEC) of Drugs controller General of India (DCGI) has recommended that Hyderabad-based Bharat Biotech can conduct phase- three trials on its intranasal vaccine. The company …
Bharat Biotech gets nod for Phase 3 trials of intranasal vaccine Read More JNS: A single dose of Covishield Vaccine administered to those recovered from the infection with SARS-CoV-2 indicated these people were more immune against Covid-19 than those who were not previously exposed, …
Single Covishield vaccine shot sufficient for recovered persons: Study Read More
बोकारो । वेदांता ग्रुप का राष्ट्रीय स्टील निर्माता ईएसएल स्टील लिमिटेड अपने ऑन-रोल कर्मचारियों के लिए ‘कोविशील्ड’ टीकाकरण अभियान का आयोजन किया है। इस अभियान का आयोजन 2 जून 2021 …
ईएसएल स्टील लिमिटेड ने अपने ऑन-रोल कर्मचारियों के लिए आयोजित किया ‘कोविशील्ड’ टीकाकरण अभियान Read More
Ashis Sinha I JNS: While the country is battling the deadly COVID-19 outbreak, new variants of the mutant Sars-Cov2 virus (B.1.617) were discovered during an investigation at Odisha’s Regional Genome …
‘Black fungus’ developing ‘hypoxia’— a silent killer Read More Ashis Sinha I JNS: The government has increased the intervals between two doses of Covishield to 12 to 16 weeks from the existing 6 to 8 weeks on Thursday. This is …
Covishield 2nd dose interval increases to 12-16 weeks Read More
JNS: An expert panel on Tuesday recommended Covaxin (COVID-19 vaccine) for phase-2 and phase-3 clinical trial on younger population aged between 2 to 18 years, official sources said. The trial …
Covaxin gets approval for phase 2, 3 trials on 2-18 year-olds Read More
Ashis Sinha I JNS: Vaccination against COVID-19 is now being attempted to be put to all people aged above 18 years. Walk-in vaccinations are not permitted for the 18-44 age …
Tools that help you to find COVID-19 vaccination slot: Expert Read More